CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) announced today that Mark Perrin, Chief Executive Officer, is scheduled to present at the 2014 Aegis Healthcare Conference to be held September 10-13, 2014 at The Encore at Wynn Las Vegas. The Company’s presentation will be on Thursday, September 11th at 10:00 a.m. PDT.
Mr. Perrin said, “InVivo has been through many important, transformational changes since the beginning of the year. I’m excited to tell the story of a streamlined and focused company with a clear path forward towards achieving our goal of developing effective therapies for spinal cord injury. This meeting is an important component of our expanding outreach to the investor, scientific and patient communities in order to establish ourselves as a leader in the spinal cord injury space.”
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, MD, who is affiliated with Massachusetts General Hospital. In 2011 the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. The publicly-traded company is headquartered in Cambridge, MA. For more details, visit, www.invivotherapeutics.com.
